Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Carotid dosimetry after re-irradiation with 131Cs permanent implant brachytherapy in recurrent, resected head and neck cancer.

Walsh A, Hubley E, Doyle L, Cognetti D, Curry J, Bar-Ad V, Luginbuhl A.

J Contemp Brachytherapy. 2019 Jun;11(3):221-226. doi: 10.5114/jcb.2019.86298. Epub 2019 Jun 28.

2.

Single institution implementation of permanent 131Cs interstitial brachytherapy for previously irradiated patients with resectable recurrent head and neck carcinoma.

Bar-Ad V, Hubley E, Luginbuhl A, Cognetti D, Curry J, Harrison AS, Johnson JM, Keller J, Peng C, To D, Doyle L.

J Contemp Brachytherapy. 2019 Jun;11(3):227-234. doi: 10.5114/jcb.2019.85778. Epub 2019 Jun 28.

3.

A nomogram to determine required seed air kerma strength in planar 131Cesium permanent seed implant brachytherapy.

Hubley E, Trager M, Bar-Ad V, Luginbuhl A, Doyle L.

J Contemp Brachytherapy. 2019 Feb;11(1):91-98. doi: 10.5114/jcb.2019.82716. Epub 2019 Feb 28.

4.

Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease.

Wernicke AG, Smith AW, Taube S, Yondorf MZ, Parashar B, Trichter S, Nedialkova L, Sabbas A, Christos P, Ramakrishna R, Pannullo SC, Stieg PE, Schwartz TH.

J Neurosurg. 2017 Apr;126(4):1212-1219. doi: 10.3171/2016.3.JNS152836. Epub 2016 Jun 3.

PMID:
27257835
5.

Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy.

Gebhardt BJ, Vargo JA, Ling D, Jones B, Mohney M, Clump DA, Ohr JP, Ferris RL, Heron DE.

Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):195-200. doi: 10.1016/j.ijrobp.2017.11.045. Epub 2017 Dec 5.

PMID:
29398127
6.

Outpatient template-guided permanent interstitial brachytherapy using 131Cs in gynecologic malignancies: Initial report.

Feddock J, Aryal P, Steber C, Edwards J, Cheek D, Randall M.

Brachytherapy. 2017 Mar - Apr;16(2):393-401. doi: 10.1016/j.brachy.2016.12.008. Epub 2017 Jan 27.

PMID:
28139423
7.

Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases.

Wernicke AG, Yondorf MZ, Peng L, Trichter S, Nedialkova L, Sabbas A, Kulidzhanov F, Parashar B, Nori D, Clifford Chao KS, Christos P, Kovanlikaya I, Pannullo S, Boockvar JA, Stieg PE, Schwartz TH.

J Neurosurg. 2014 Aug;121(2):338-48. doi: 10.3171/2014.3.JNS131140. Epub 2014 May 2.

8.

Cesium-131 permanent seed brachytherapy: dosimetric evaluation and radiation exposure to surgeons, radiation oncologists, and staff.

Parashar B, Wernicke AG, Pavese A, Singh P, Trichter S, Sabbas A, Kutler DI, Kuhel W, Port JL, Lee PC, Nori D, Chao KS.

Brachytherapy. 2011 Nov-Dec;10(6):508-13. doi: 10.1016/j.brachy.2011.04.002. Epub 2011 Jun 2.

PMID:
21640663
9.

Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas.

Brachman DG, Youssef E, Dardis CJ, Sanai N, Zabramski JM, Smith KA, Little AS, Shetter AG, Thomas T, McBride HL, Sorensen S, Spetzler RF, Nakaji P.

J Neurosurg. 2018 Dec 21:1-10. doi: 10.3171/2018.7.JNS18656. [Epub ahead of print]

PMID:
30579269
10.

Re-resection with brachytherapy for locally recurrent soft tissue sarcoma arising in a previously radiated field.

Pearlstone DB, Janjan NA, Feig BW, Yasko AW, Hunt KK, Pollock RE, Lawyer A, Horton J, Pisters PW.

Cancer J Sci Am. 1999 Jan-Feb;5(1):26-33.

PMID:
10188058
11.

Implementation and early clinical results utilizing Cs-131 permanent interstitial implants for gynecologic malignancies.

Wooten CE, Randall M, Edwards J, Aryal P, Luo W, Feddock J.

Gynecol Oncol. 2014 May;133(2):268-73. doi: 10.1016/j.ygyno.2014.02.015. Epub 2014 Feb 17.

12.

Cesium-131 brachytherapy in high risk and recurrent head and neck cancers: first report of long-term outcomes.

Pham A, Arora S, Wernicke AG, Kutler DI, Cohen M, Kuhel W, Trichter S, Nori D, Formenti SC, Parashar B.

J Contemp Brachytherapy. 2015 Dec;7(6):445-52. doi: 10.5114/jcb.2015.56764. Epub 2015 Dec 30.

13.

A radiobiological investigation on dose and dose rate for permanent implant brachytherapy of breast using I125 or P103d sources.

Baltas D, Lymperopoulou G, Löffler E, Mavroidis P.

Med Phys. 2010 Jun;37(6Part1):2572-2586. doi: 10.1118/1.3426027.

PMID:
28512983
14.

Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results.

Puthawala A, Nisar Syed AM, Gamie S, Chen YJ, Londrc A, Nixon V.

Int J Radiat Oncol Biol Phys. 2001 Oct 1;51(2):354-62.

PMID:
11567809
15.

Decline of dose coverage between intraoperative planning and post implant dosimetry for I-125 permanent prostate brachytherapy: comparison between loose and stranded seed implants.

Moerland MA, van Deursen MJ, Elias SG, van Vulpen M, Jürgenliemk-Schulz IM, Battermann JJ.

Radiother Oncol. 2009 May;91(2):202-6. doi: 10.1016/j.radonc.2008.09.013. Epub 2008 Oct 22.

PMID:
18950884
16.

Feasibility report for retreatment of locally recurrent head-and-neck cancers by combined brachy-chemotherapy using frameless image-guided 3D interstitial brachytherapy.

Krempien RC, Grehn C, Haag C, Straulino A, Hensley FW, Kotrikova B, Hofele C, Debus J, Harms W.

Brachytherapy. 2005;4(2):154-62.

PMID:
15893270
17.
18.
19.

[CT-guidance interstitial Iodine-125 seed brachytherapy as a salvage therapy for recurrent head and neck carcinoma].

Jiang YL, Ji Z, Tian SQ, Guo FX, Yuan HS, Liu C, Sun HT, Wang JJ.

Zhonghua Yi Xue Za Zhi. 2018 Dec 4;98(45):3686-3691. doi: 10.3760/cma.j.issn.0376-2491.2018.45.011. Chinese.

PMID:
30526780
20.

Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant.

Lawenda BD, Taghian AG, Kachnic LA, Hamdi H, Smith BL, Gadd MA, Mauceri T, Powell SN.

Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):671-80.

PMID:
12788172

Supplemental Content

Support Center